Filing Details
- Accession Number:
- 0000899243-20-004179
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-11 21:23:30
- Reporting Period:
- 2020-02-11
- Accepted Time:
- 2020-02-11 21:23:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1681087 | Avrobio Inc. | AVRO | Biological Products, (No Disgnostic Substances) (2836) | 810710585 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741849 | Geoffrey Mackay | C/O Avrobio, Inc. 1 Kendall Sq. Bldg 300, Ste 201 Cambridge MA 02139 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-02-11 | 44,596 | $27.36 | 364,927 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-02-11 | 18,404 | $28.10 | 346,523 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 72,604 | Indirect | By son of reporting person |
| Common Stock | 72,604 | Indirect | By daughter of reporting person |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.995, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.35, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
